MYSEC-PM (Secondary Myelofibrosis Survival)
MYSEC-PM (Secondary Myelofibrosis Survival) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the MYSEC-PM (Secondary Myelofibrosis Survival) → Runs in your browser. No signup, no tracking.
What this is
MYSEC-PM (Secondary Myelofibrosis Survival) is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. MYSEC-PM (Secondary Myelofibrosis Survival) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
When to use it
Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.
References
Passamonti F, Giorgino T, Mora B, et al. A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis. Leukemia. 2017;31(12):2726-2731. Read the source ↗
Worked example: MYSEC-PM 13.75 — intermediate-1 risk (≥ 11 to < 14).
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.